Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease

Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis

(2013) I.M. Miller et al.   BRITISH JOURNAL OF DERMATOLOGY

Neutrophil-Derived Cathelicidin Promotes Adhesion of Classical Monocytes

(2013) Sarawuth Wantha et al.   CIRCULATION RESEARCH

Psoriasis Is Not Associated with Atherosclerosis and Incident Cardiovascular Events: The Rotterdam Study

(2013) Emmilia A. Dowlatshahi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions

(2013) Andrew L. Croxford et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients

(2013) Hesham Abd El-Moaty Zaher et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Transforming Growth Factor-  Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17-Dependent Pathway

(2013) A. Gistera et al.   Science Translational Medicine

Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis

(2012) Senem Buyukkara Yilmaz et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension

(2012) Hoanglan Nguyen et al.   CARDIOVASCULAR RESEARCH

Risk and predictors of cardiovascular disease in psoriasis: a population-based study

(2012) Hilal Maradit-Kremers et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Blockade of Phosphatidylinositol 3-Kinase (PI3K)δ or PI3Kγ Reduces IL-17 and Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis

(2012) Anne Roller et al.   JOURNAL OF IMMUNOLOGY

An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling

(2012) Khalifa El Malki et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

To Be 17 Again — Anti–Interleukin-17 Treatment for Psoriasis

(2012) Ari Waisman   NEW ENGLAND JOURNAL OF MEDICINE

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

(2012) Kim A. Papp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

(2012) Craig Leonardi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events

(2011) Nehal N. Mehta et al.   AMERICAN JOURNAL OF MEDICINE

Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography –Computed Tomography (FDG-PET/CT)

(2011) Nehal N. Mehta   ARCHIVES OF DERMATOLOGY

Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction

(2011) Philip Wenzel et al.   CIRCULATION

Psoriasis and atherosclerosis: two plaques, one syndrome?

(2011) A. J. Flammer et al.   EUROPEAN HEART JOURNAL

Functional Specialization of Interleukin-17 Family Members

(2011) Yoichiro Iwakura et al.   IMMUNITY

Distribution and Categorization of Left Ventricular Measurements in the General Population

(2010) Philipp S. Wild et al.   Circulation-Cardiovascular Imaging

Psoriasis and cardiovascular disease

(2010) Gino A. Vena et al.   Dermatologic Therapy

Inflammation, Immunity, and Hypertension

(2010) David G. Harrison et al.   HYPERTENSION

Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease

(2010) Reiko M. Onishi et al.   IMMUNOLOGY

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

(2009) N. N. Mehta et al.   EUROPEAN HEART JOURNAL

Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction

(2009) Meena S. Madhur et al.   HYPERTENSION

Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

(2009) Vinod Chandran et al.   JOURNAL OF AUTOIMMUNITY

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

(2009) Soraya Taleb et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice

(2009) C. Erbel et al.   JOURNAL OF IMMUNOLOGY

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

(2009) L. van der Fits et al.   JOURNAL OF IMMUNOLOGY

Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis

(2009) Erin G. Harper et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

(2009) Antonella Di Cesare et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction

(2008) Thomas Münzel et al.   ANNALS OF MEDICINE

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

(2008) Michelle A. Lowes et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis

(2008) DD Balci et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY